Garadacimab and csl112, page-9

  1. 7,857 Posts.
    lightbulb Created with Sketch. 2481
    Well there you go, I wasnt far off from memory.

    I definitely remember GS had low expectations for CSL112 based on related failures from other players.

    Ascribing a 10% chance of success is very low and I dont think people understand that the chances CSL112 goes commercial are not great. Maybe GS a wrong, but I dont think they are thaat wrong.

    If you've got the report there handy could you post the bit where they discuss the concerns with 112?
    Last edited by JoeGambler: 11/01/24
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$265.50
Change
1.550(0.59%)
Mkt cap ! $128.5B
Open High Low Value Volume
$264.45 $265.88 $259.33 $230.1M 870.8K

Buyers (Bids)

No. Vol. Price($)
1 27 $265.30
 

Sellers (Offers)

Price($) Vol. No.
$265.80 79 1
View Market Depth
Last trade - 16.12pm 23/07/2025 (20 minute delay) ?
CSL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.